Orville Murray
Psychiatric/Mental Health · Orlando, FLNPI 1700344686
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,422 of the $13,319 with a category attached, or 78.2%. 28 manufacturers reported payments, led by AbbVie at 39.4% of the total. Reporting peaked in 2022 at $6,624 and has fallen 83.7% since, to $1,083 in 2025. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 451 payments — averaging $29.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Alkermes, Inc.$2K
- Johnson & Johnson$877
- Corium, LLC$786
- Supernus Pharmaceuticals, Inc.$608
- Otsuka America Pharmaceutical, Inc.$520
- plus $3K from 22 others
What the payments were for
- Speaking & faculty fees$2,75021%
- Travel & lodging$330%
- Food & beverage$10,42278%
- Education$1141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 97 | $5,246 |
| Alkermes, Inc. | 62 | $2,002 |
| Johnson & Johnson | 29 | $877 |
| Corium, LLC | 37 | $786 |
| Supernus Pharmaceuticals, Inc. | 46 | $608 |
| Otsuka America Pharmaceutical, Inc. | 21 | $520 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $445 |
| Vanda Pharmaceuticals Inc. | 17 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $363 |
| Lundbeck LLC | 14 | $311 |
| Neurocrine Biosciences, Inc. | 12 | $272 |
| Sunovion Pharmaceuticals Inc. | 18 | $263 |
| Axsome Therapeutics, Inc. | 11 | $260 |
| Ironshore Pharmaceuticals Inc. | 9 | $181 |
| Validus Pharmaceuticals LLC | 3 | $151 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Eisai Inc. | 5 | $93 |
| Neos Therapeutics, LP | 5 | $79 |
| Noven Therapeutics, LLC | 3 | $65 |
| Bausch Health US, LLC | 3 | $62 |
| Tris Pharma Inc | 3 | $54 |
| Indivior Inc. | 2 | $45 |
| Almatica Pharma LLC | 2 | $38 |
| Harmony Biosciences LLC | 1 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,451
- LYBALVI$1,888
- ARISTADA$500
- SPRAVATO$200
- ARISTADA INITIO$125
- VIVITROL$125
- INVEGA SUSTENNA$124
How this compares
$13,319 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $335 |
| Diazepam | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.